iShares U.S. Pharmaceuticals ETF $IHE Holdings Boosted by Raleigh Capital Management Inc.

Raleigh Capital Management Inc. increased its position in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 1,723.4% during the third quarter, Holdings Channel.com reports. The firm owned 7,093 shares of the company’s stock after buying an additional 6,704 shares during the quarter. Raleigh Capital Management Inc.’s holdings in iShares U.S. Pharmaceuticals ETF were worth $713,000 as of its most recent SEC filing.

Other hedge funds have also bought and sold shares of the company. Balance Wealth Partners LLC bought a new stake in iShares U.S. Pharmaceuticals ETF during the 3rd quarter valued at $42,000. Root Financial Partners LLC bought a new position in shares of iShares U.S. Pharmaceuticals ETF in the third quarter valued at $51,000. Congress Asset Management Co. bought a new position in shares of iShares U.S. Pharmaceuticals ETF in the third quarter valued at $56,000. Trust Co. of Vermont acquired a new position in shares of iShares U.S. Pharmaceuticals ETF during the second quarter valued at about $60,000. Finally, Turtle Creek Wealth Advisors LLC acquired a new position in shares of iShares U.S. Pharmaceuticals ETF during the third quarter valued at about $64,000.

iShares U.S. Pharmaceuticals ETF Price Performance

Shares of NYSEARCA IHE opened at $107.61 on Friday. The company has a 50-day moving average price of $102.41 and a 200-day moving average price of $94.74. The stock has a market capitalization of $1.61 billion, a P/E ratio of 17.75 and a beta of 0.47. iShares U.S. Pharmaceuticals ETF has a 1 year low of $74.93 and a 1 year high of $109.43.

About iShares U.S. Pharmaceuticals ETF

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.